マスイ　ケンタ   Masui Kenta   増井　憲太    所属   医学部 医学科    職種   准教授
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody.
掲載誌名	正式名：BioMed research international. ISSNコード：23146133/23146141
掲載区分	国外
巻・号・頁	10,pp.1-12
著者・共著者	MASUI Kenta†, KOMORI Takashi, KATO, Yukinari, MASUTOMI,Kenkichi Kenkichi, ICHIMURA Koichi, OGASAWARA Satoshi, KANEKO Mika K, OKI Hiroharu, SUZUKI Hiroyoshi, NITTA Masayuki, MARUYAMA Takashi, MURAGAKI Yoshihiro, KAWAMATA Takakazu, SAWADA Tatsuo, SHIBATA Noriyuki
担当区分	筆頭著者
発行年月	2018/03
概要	Telomerase reverse transcriptase (TERT) is important for the biology of diffuse gliomas. TERT promoter mutations are selectively observed among 1p/19q-codeleted oligodendrogliomas and isocitrate dehydrogenase gene- (IDH-) wildtype glioblastoma (GBM). However, TERT transcripts range widely in various cancers including gliomas, and TERT protein expression has been rarely investigated thus far. It would be thus critical to examine the expression level of TERT in tumors in addition to its mutational status, and sensitive and specific methods are urgently needed to examine TERT protein expression for the assessment of TERT biology in gliomas. Using our newly developed TERT-specific monoclonal antibody (TMab-6) applicable to human tissue, we found an unexpected increase in TERT expression in TERT-wildtype as well as TERT-mutated gliomas and in tumor vasculature. This is the first extensive analysis on the expression of TERT immunoreactivity in human glioma tissue, suggesting that TERT protein expression may be regulated by several mechanisms in addition to its promoter mutation.
DOI	10.1155/2018/7945845
PMID	29693015